Avenue Therapeutics, Inc. - stock earnings
ATXI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 640000 USD | ? USD |
| 2023Q3 | 526000 USD | ? USD |
| 2023Q2 | -4.0 million USD | ? USD |
| 2023Q1 | -8.7 million USD | ? USD |
| 2022Q4 | 5.0 million USD | ? USD |
| 2022Q3 | -660000 USD | ? USD |
| 2022Q2 | -603000 USD | ? USD |
| 2022Q1 | -2.9 million USD | ? USD |
| 2021Q4 | -913000 USD | ? USD |
| 2021Q3 | -871000 USD | ? USD |
| 2021Q2 | -949000 USD | ? USD |
| 2021Q1 | -998000 USD | ? USD |
| 2020Q4 | -993000 USD | ? USD |
| 2020Q3 | -1.0 million USD | ? USD |
| 2020Q2 | -1.9 million USD | ? USD |
| 2020Q1 | -1.2 million USD | ? USD |
| 2019Q4 | -5.4 million USD | ? USD |
| 2019Q3 | -2.2 million USD | ? USD |
| 2019Q2 | -7.0 million USD | ? USD |
| 2019Q1 | -11.3 million USD | ? USD |
| 2018Q4 | -3.9 million USD | ? USD |
| 2018Q3 | -2.6 million USD | ? USD |
| 2018Q2 | -4.7 million USD | ? USD |
| 2018Q1 | -10.4 million USD | ? USD |
| 2017Q4 | -6.2 million USD | ? USD |
| 2017Q3 | -2.9 million USD | ? USD |
| 2017Q2 | -2.4 million USD | ? USD |
| 2017Q1 | -661000 USD | ? USD |
| 2016Q4 | -815000 USD | ? USD |
| 2016Q3 | -544000 USD | ? USD |
| 2016Q2 | -771000 USD | ? USD |
| 2016Q1 | -1.0 million USD | ? USD |
| 2015Q4 | -5.7 million USD | ? USD |
ATXI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.4 million USD | ? USD |
| 2022 | 2.0 million USD | ? USD |
| 2021 | -3.7 million USD | ? USD |
| 2020 | -5.1 million USD | ? USD |
| 2019 | -25.6 million USD | ? USD |
| 2018 | -21.3 million USD | ? USD |
| 2017 | -12.3 million USD | ? USD |
| 2016 | -3.2 million USD | ? USD |
| 2015 | -5.2 million USD | ? USD |
ATXI
Price: $6.20
52 week price:
Earnings Per Share: -0.98 USD
P/E Ratio: -0.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 246300
Market Capitalization: 6.6 million